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1Chapter
Should We Do Bilateral Internal 
Mammary Artery Grafting in 
Diabetic Patients?
Hassane Abdallah, Ahmed Ibrahim and Khalid Al Khamees
Abstract
Nowadays, potential advantages of BIMA grafting are recognized overall in terms 
of long-term survival1 and by not increasing operative morbidity. One of the major 
restrictions for extending the use of BIMA grafting is the current impossibility of 
generalizing the procedure to higher risk patients. These results tend to confirm 
recent results that promote the use of BIMA grafting in every kind of patients and 
consequently to confirm the generalization of the procedure, without being afraid 
of sternal complications. The absence of deep sternal wound infection in our study 
shows that there is no contraindication of BITA grafting among diabetic patients.
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1. Background
Coronary artery disease (CAD) is the most common pathology which prepos-
sesses cardiologists and cardiac surgeons in the past century. Ischemic heart disease 
was also the most common reason of mortality in the world as reported by the 
World Health Organization in 2018 [1].
While Coronary artery bypass grafting (CABG) is the preferred therapeutic 
option for ischemic heart disease in diabetic patients, surgical modalities of the pro-
cedure are still debated. One of these is the choice of grafts. Single internal-thoracic-
artery graft has resulted in a 10-year rate of angiographic patency exceeding 90%, 
as compared with 50% for vein grafts. These excellent long-term outcomes have 
stimulated the use of a bilateral internal-thoracic-artery approach. Nevertheless, the 
technique is associated to a major drawback. By compromising severely the sternal 
vascularization, the BIMA may expose patients higher rates of sternal wound infec-
tion and this risk seems to be particularly increased in diabetic patients.
The purpose of this chapter is to assess, according to our experience and litera-
ture review, the feasibility and the safety of BIMA in patients with diabetes under-
going CABG. Furthermore, the paper highlighted the importance of some cautions 
and adjunct measures that should be adopted systematically.
2. Patients and methods
A retrospective analysis of the patients who underwent coronary artery bypass 
surgery in our institution from January 2017 to January 2019 was performed. All 
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the data were retrieved from computer based medical records. All patients were 
followed-up in our hospital after the discharge.
The incidence of postoperative sternal wound infections in diabetic patients who 
received bilateral internal thoracic artery grafting was compared with the incidence 
Variable Total Diabetic 
(n = 116)
Non –diabetic 
(n = 94)
P value
Age 52.1 ± 9 52.9 ± 7.9 51. 04 ± 10.2 0.2
≤50 year 98(47%) 50(24%) 48(23%) 0.3
>50 year 112(53%) 66(31%) 46(22%)
Sex
Female 10(5%) 4(2%) 6(3%) 0.3
Male 200(95%) 112(53%) 88(42%)
HbAIc(mean ± SD) 7.8 ± 1.8 8.8 ± 1.6 6.1 ± 0.7 0.0001
≤7 95(45%) 27(13%) 65(31%) 0.0001
>7 78(37%) 71(34%) 8(4%)
≥10 37(18%) 39(18%) 0(0%)
HbAIc > 7 and BMI > 30 69(33%) 63(54%) 6(6%) 0.0001
BMI(mean ± SD) 29.1 ± 4.6 29.2 ± 4.7 28.7 ± 4.5 0.5
<25 59(28%) 29(14%) 29(14%) 0.3
25–30 76(36%) 46(22%) 29(14%)
>30–35 52(25%) 32(15%) 21(10%)
>35–40 23(11%) 13(6%) 11(5%)
EF
<30 34(16%) 21(10%) 13(6%) 0.7
30–50 69(33%) 40(19%) 29(14%)
>50 107(51%) 59(28%) 48(23%)
Table 1. 
Preoperative characteristics (n = 210).
Variable Diabetic Non-diabetic P value
Number of coronary by anastomosis (mean) 2.7 2.6 0.4
Y fashion
No 99(47%) 73(35%) 0.6
Yes 23(11%) 15(7%)
Pump
Off 72(35%) 60(29%) 0.7
On 44(21%) 34(16%)
Cross clamp time in minutes (Mean ± SD) 37 ± 6 41 ± 7 0.002
Bypass surgery time in minutes (Mean ± SD) 52 ± 8 57 ± 9 0.001
Duration of surgery in minutes (Mean ± SD) 227 ± 12 233 ± 13 0.005
Table 2. 
Postoperative characteristics.
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in non-diabetic patients. Two-hundred and ten patients who underwent CABG 
using bilateral internal thoracic arteries were enrolled in the study and were divided 
into two groups: group I diabetic patients (DM) (n = 116) and group II non-diabetic 
patients (non-DM) patients (n = 94) (Tables 1–4).
3. Surgical procedures
All patients were disinfected with dermic isobetadine (iso-Betadine Dermique, 
10% solution, povidone iodine) on their whole body. A lateral drape with plastic 
protector was used. All procedures were performed via median sternotomy. IMAs 
were harvested in a skeletonized fashion since only the artery is carefully dissected 
off the chest wall. Once upon completion of harvesting, IMAs were prepared with 
papaverine.
Extracorporeal circulation (ECC) was used in 78 patients whereas off-pump 
CABG was performed in 132 patients.
Combinations and numbers of arterial bypasses were selected according to the 
angiographic findings. When the bilateral internal mammary artery (BIMA) was 
grafted in situ, the left internal mammary artery (LIMA) was generally used for 
the left descending artery (LAD) and the RIMA for the lateral wall, usually going 
In Situ. In 38 patients having a Y-graft, the left coronary system was chosen as the 
target site of revascularization and a saphenous graft was used if necessary. The 
mean number of distal anastomosis was 2.6.
Before sternal closure, mediastinum was irrigated with warm saline and topi-
cal Vancomycin was routinely applied. Interlocking Multi-twisted closure sternal 
technique was used (Table 2).
Variable Diabetic  
(n = 116)
Non-diabetic 
(n = 94)
Difference 95% CI
Post-operative IABP 2 (1.7%) 1(1.1%) 0.6 −4.3 − 5.0
Atrial fibrillation 12 (10.4%) 8(8.8%) 1.6 −7.0 − 9.7
Post-operative stroke 0 0
Diaphragmatic paralysis 0 1(1.1%) 1.1 −2.2 − 5.8
Pleural effusion 1(0.9%) 2(2.1%) 1.2 −2.9 − 6.5
Hospital acquired pneumonia 2(1.7%) 1(1.1%) 0.6 −4.3 − 5.0
Low cardiac output 2(1.7%) 1(1.1%) 0.6 −4.3 − 5.0
Bleeding re-operation 0 0
ICU stay in day (mean) 4 3 1.0 0.6 − 1.4
Table 3. 
Postoperative morbidity.
Variable Diabetic  
(n = 116)
Non-diabetic 
(n = 94)
Difference 95% CI
Superficial Wound Infection 2(1.7%) 1(1.1%) 0.6 −4.3 − 5.0
Deep sternal wound infection 0 0 NA
Mortality 2(1.7%) 1(1.1%) 0.6 −4.3 − 5.0
Table 4. 
Postoperative infection and the mortality rate.
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4. Data analysis
Statistical Package for Social and Sciences (SPSS) version was used for data 
management. Descriptive data analysis was performed and data were presented in 
number (n) and percentages (%). Mean ± SD was reported for continuous vari-
ables. Statistical signıfıcance difference was assessed by using T-test for continuous 
variables and Chi squared for categorical variables and proportion, P value of 
(<0.05) was considered significant [2, 3].
5. Results
We included 210 patients, men (n = 200) and women (n = 10). The median age 
was 52.1 +/−9 years, 116 patients were DM and 100 patients of them in insulin, the 
median BMI was 29.1+/−4.6 kg/m2 and the mean Euro SCORE was 4.8.
Overall operative mortality was 2.8% and was recorded in three high risk 
patients with severe LV systolic dysfunction (ejection fraction < 30%).
No statistical difference between the two groups was observed. There were 
no stroke or transient neurologic accident happened among our patients even no 
reoperation for bleeding (Table 3).
Deep sternal wound infection occurred in none off our patients. Only three 
cases showed signs of superficial wound infection that healed promptly following 
daily dressing, antibiotics and strict glycemic control (Table 4).
6. Discussion
Since 1980s, internal mammary artery (IMA) has become the graft of choice, 
thanks to clinical and angiographic data showing its long term patency rates and its 
superiority over the saphenous vein graft. Subsequently, the use of more arterial 
grafts especially bilateral mammary arteries was studied to achieve better long-term 
results when compared to single IMA and SVG. Interestingly, many analyses have 
demonstrated that patients undergoing CABG with bilateral internal mammary 
artery (BIMA) grafting have significantly improved survival and freedom from 
repeat revascularization when compared with patients receiving a single internal 
mammary artery (SIMA) [4].
Accordingly, the use of BIMA in diabetics was studied as long as CABG has 
emerged as the best option of myocardial revascularization in this group [5]. 
However, in spite of Histological superiority of IMA and the improved outcomes, 
the use of BIMA in patients with diabetes mellitus is still debated mainly due to the 
higher risk of sternal infection which remains a life-threatening complication after 
cardiac surgery associated with increased morbidity and mortality.
The ART trial is the first randomized study that compares outcome of single 
and bilateral internal thoracic artery grafting for CABG. Survival after BIMA 
versus SIMA grafting is being assessed by the randomized controlled Arterial 
Revascularization Trial (ART) [6]. Analysis of early data from this trial demon-
strated similar surgical mortality and major morbidity for both the SIMA and the 
BIMA groups at 30 days and 1 year but with a small increase in the need for sternal 
wound reconstruction using BIMA. In our study BIMA used in selected diabetic 
patients do not lead to a significant higher incidence of deep sternal wound infec-
tion. We did not get the late survival advantage of using both internal thoracic 
arteries in this cohort. These results support the feasibility of CABG using BIMA 
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grafts in patients undergoing CABG however Special cautions should to use BIMA 
in diabetics have been highlighted [7, 8].
Recently, it has been suggested that the skeletonization technique of internal 
thoracic artery reduces the risk of deep sternal wound complications by preserving 
sternal vascularization. Furthermore, a recent meta-analysis compared the inci-
dence of sternal wound infection in diabetic patients undergoing skeletonized and 
pedicled IMA harvest. While pedicled BIMA harvest clearly increases the risk of 
DSWI, skeletonized BIMA harvest can be safely performed in diabetic patients [6].
Similarly, other measures should be applied in order to reduce the risk of sternal 
wound infection especially in diabetic patients. A recent prospective study showed 
the importance of a tight glycemic control with continuous intravenous insulin 
infusion- in comparison with fractional subcutaneous insulin injections, reduces 
significantly serum glucose levels and leads to a significant reduction in deep sternal 
wound infection rates [9]. Other studies highlighted that patients receiving topical 
vancomycin before closure of the incision had less superficial sternal infections (0% 
vs. 1.6%; P < 0.0001), deep sternal infections (0% vs. 0.7%; P = 0.005), any type 
of sternal infection (0% vs. 2.2%; P < .0001) and more interestingly a significant 
decrease in sternal infections of any type in patients with diabetes mellitus (0% vs. 
3.3%; P = 0.0004). As a conclusion they mentioned that topical vancomycin applied 
to the sternal edges, in conjunction with perioperative antibiotics and controlled 
glycemic level, helps to eliminate wound infections in cardiac surgical patients [10].
Contraindications to bilateral IMAs, according to the ART Trial, would 
be insulin-dependent diabetes mellitus, specifically in obese individuals, and 
chronic obstructive airways disease with some early shoots of higher complica-
tions in women and the elderly, which were thus relative contraindications [11]. 
Nevertheless, our protocol reveals that the feasibility of the double mammary in 
insulin -dependent diabetic patients without affecting the incidence of deep sternal 
wound infection, in condition with tight glycemic control and strict hygiene during 
perioperative period.
7. Conclusions
Excellent outcomes following BIMA grafting can be expected in diabetic 
patients with a similar morbimortality compared to non-diabetic patients. Thus, 
use of BIMA grafting is an acceptable surgical procedure technique for diabetic 
patients. It provides multiple grafting with the best arterial conduits (IMAs) 
and is associated with an acceptable risk of deep sternal infections provided that 
preventive measures are taken. Indeed, adherence to a policy of strict perioperative 
glycemic control, good surgical technique, skeletonization, as well as effective post-
operative management of surgical wounds would maximize the adoption of BIMA 
grafting as a default revascularization strategy even for diabetic patients. Further 
randomized controlled trials with longer follow-up are needed to confirm the safety 
and efficiency of BIMA grafting in diabetics.
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